These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease. Schöll M; Ossenkoppele R; Strandberg O; Palmqvist S; ; Jögi J; Ohlsson T; Smith R; Hansson O Brain; 2017 Sep; 140(9):2286-2294. PubMed ID: 29050382 [TBL] [Abstract][Full Text] [Related]
23. Networks of tau distribution in Alzheimer's disease. Hoenig MC; Bischof GN; Seemiller J; Hammes J; Kukolja J; Onur ÖA; Jessen F; Fliessbach K; Neumaier B; Fink GR; van Eimeren T; Drzezga A Brain; 2018 Feb; 141(2):568-581. PubMed ID: 29315361 [TBL] [Abstract][Full Text] [Related]
24. Atypical Localization and Dissociation between Glucose Uptake and Amyloid Deposition in Cognitively Normal APOE*E4 Homozygotic Elders Compared with Patients with Late-Onset Alzheimer's Disease. Pardo JV; Lee JT; eNeuro; 2018; 5(1):. PubMed ID: 29497704 [TBL] [Abstract][Full Text] [Related]
26. Age-dependent metabolic dysregulation in cancer and Alzheimer's disease. Harris RA; Tindale L; Cumming RC Biogerontology; 2014 Dec; 15(6):559-77. PubMed ID: 25305052 [TBL] [Abstract][Full Text] [Related]
27. β-amyloid monomers drive up neuronal aerobic glycolysis in response to energy stressors. Santangelo R; Giuffrida ML; Satriano C; Tomasello MF; Zimbone S; Copani A Aging (Albany NY); 2021 Jul; 13(14):18033-18050. PubMed ID: 34290150 [TBL] [Abstract][Full Text] [Related]
28. Loss of Brain Aerobic Glycolysis in Normal Human Aging. Goyal MS; Vlassenko AG; Blazey TM; Su Y; Couture LE; Durbin TJ; Bateman RJ; Benzinger TL; Morris JC; Raichle ME Cell Metab; 2017 Aug; 26(2):353-360.e3. PubMed ID: 28768174 [TBL] [Abstract][Full Text] [Related]
29. Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study. Chiaravalloti A; Barbagallo G; Ricci M; Martorana A; Ursini F; Sannino P; Karalis G; Schillaci O Brain Res; 2018 Jan; 1678():116-122. PubMed ID: 29066367 [TBL] [Abstract][Full Text] [Related]
30. Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ ) deposition. Vlassenko AG; Vaishnavi SN; Couture L; Sacco D; Shannon BJ; Mach RH; Morris JC; Raichle ME; Mintun MA Proc Natl Acad Sci U S A; 2010 Oct; 107(41):17763-7. PubMed ID: 20837517 [TBL] [Abstract][Full Text] [Related]
31. Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease. Brier MR; Gordon B; Friedrichsen K; McCarthy J; Stern A; Christensen J; Owen C; Aldea P; Su Y; Hassenstab J; Cairns NJ; Holtzman DM; Fagan AM; Morris JC; Benzinger TL; Ances BM Sci Transl Med; 2016 May; 8(338):338ra66. PubMed ID: 27169802 [TBL] [Abstract][Full Text] [Related]
32. Head to head comparison of [ Jang YK; Lyoo CH; Park S; Oh SJ; Cho H; Oh M; Ryu YH; Choi JY; Rabinovici GD; Kim HJ; Moon SH; Jang H; Lee JS; Jagust WJ; Na DL; Kim JS; Seo SW Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):432-442. PubMed ID: 29143870 [TBL] [Abstract][Full Text] [Related]
33. Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults. Dumurgier J; Hanseeuw BJ; Hatling FB; Judge KA; Schultz AP; Chhatwal JP; Blacker D; Sperling RA; Johnson KA; Hyman BT; Gómez-Isla T J Alzheimers Dis; 2017; 60(4):1451-1459. PubMed ID: 29036824 [TBL] [Abstract][Full Text] [Related]
34. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators. Alavi A; Newberg AB; Souder E; Berlin JA J Nucl Med; 1993 Oct; 34(10):1681-7. PubMed ID: 8410281 [TBL] [Abstract][Full Text] [Related]
35. PET of brain amyloid and tau in mild cognitive impairment. Small GW; Kepe V; Ercoli LM; Siddarth P; Bookheimer SY; Miller KJ; Lavretsky H; Burggren AC; Cole GM; Vinters HV; Thompson PM; Huang SC; Satyamurthy N; Phelps ME; Barrio JR N Engl J Med; 2006 Dec; 355(25):2652-63. PubMed ID: 17182990 [TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal Fluid Biomarkers are Differentially Related to Structural and Functional Changes in Dementia of the Alzheimer's Type. Malpas CB; Saling MM; Velakoulis D; Desmond P; Hicks RJ; Zetterberg H; Blennow K; O'Brien TJ J Alzheimers Dis; 2018; 62(1):417-427. PubMed ID: 29439322 [TBL] [Abstract][Full Text] [Related]
37. Tau positron emission tomography using [ Kang JM; Lee SY; Seo S; Jeong HJ; Woo SH; Lee H; Lee YB; Yeon BK; Shin DH; Park KH; Kang H; Okamura N; Furumoto S; Yanai K; Villemagne VL; Seong JK; Na DL; Ido T; Cho J; Lee KM; Noh Y Neurobiol Aging; 2017 Nov; 59():210-219. PubMed ID: 28890300 [TBL] [Abstract][Full Text] [Related]
38. Tau pathology and cognitive reserve in Alzheimer's disease. Hoenig MC; Bischof GN; Hammes J; Faber J; Fliessbach K; van Eimeren T; Drzezga A Neurobiol Aging; 2017 Sep; 57():1-7. PubMed ID: 28577411 [TBL] [Abstract][Full Text] [Related]